Concussion

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Calgary for Phase 2 Trial of Psilocybin-Assisted Therapy for PTSD in Survivors of Intimate Partner Violence

UpRight Science Brings Together Expert Advisory Board to Advance Balance as an Essential Health Measure

Multidisciplinary group brings expertise across medicine, neuroscience, healthcare technology, business, and communications to support the company's mission to make balance...

BRAINBox Solutions Announces Agreement with Prolight Diagnostics for Commercial Supply of Pyros® Devices for Delivery of BRAINBox Concussion Diagnostics/Prognostics at Point-of-Care

Company reports additional progress in expanding its patent portfolio for concussion and neurodegenerative disease testingRICHMOND, Va., Sept. 14, 2026 /PRNewswire/...

BetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA-Precedented Serotonergic Mechanism

Fully non-hallucinogenic, oral, non-scheduled 5-HT2A neuroplastogen differentiates BETR-001 from every other 5-HT2A agonist program; depression and other psychiatric disorders retained...

ZetrOZ Systems Introduces sam 3.0 Multi-hour Continuous Ultrasound Wearable Technology, The Next Evolution in Recovery

The inventors of sustained acoustic medicine unveil advancements in the clinically validated, FDA-cleared device that revolutionizes recovery from soft-tissue injuries...

error: Content is protected !!